Relation of Monocyte Number to Progression of Aortic Stenosis

Kangning Han1, Yihua Xia1, Dongmei Shi1

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University.

Insights

High monocyte counts are linked to faster aortic stenosis progression. This finding suggests monocytes may play a role in the worsening of aortic stenosis, impacting patient prognosis.

Area of Science:

  • Cardiology
  • Hematology
  • Medical Research

Background:

  • Rapid progression of aortic stenosis (AS) correlates with adverse patient outcomes.
  • The specific relationship between monocyte count and the rate of AS progression remains unclear.

Purpose of the Study:

  • To investigate the association between monocyte count and the progression rate of aortic stenosis.
  • To determine if monocyte levels can predict rapid AS progression.

Main Methods:

  • Retrospective analysis of 220 patients with AS and serial echocardiograms (≥180 days apart).
  • AS severity assessed by aortic jet velocity (Vmax) and mean pressure gradient.
  • Rapid progression defined as Vmax increase ≥0.3 m/s/year; patients grouped by low/high monocyte counts.

Main Results:

  • Over a median follow-up of 601 days, 52.7% of patients experienced rapid AS progression.
  • The high monocyte group exhibited significantly faster progression in Vmax and mean pressure gradient (p=0.020, p=0.030).
  • Severe AS incidence increased more in the high monocyte group (16.9%) compared to the low monocyte group (5.4%).

Conclusions:

  • Elevated monocyte counts are significantly associated with rapid aortic stenosis progression.
  • Monocyte number serves as a potential predictive marker for accelerated AS progression.
  • Further research into the mechanisms linking monocytes to AS progression is warranted.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
65
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
69
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
40
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
137
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
62
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
59